Please assess the completion status of the following clinical trial:

Trial Title: Pethema Multiple Myeloma 2000

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Less 70 years~* ECOG 0-2~* Symptomatic MM (pain, anemia, infection, haemorrhage, loss of weight, hypercalcemia, extramedulary plasmocytoma, creatinine \>2 mg/dl).~* No previous chemotherapy~Exclusion Criteria:~* \>70 years~* ECOG 3-4~* myeloma quiescent~* cardiopathy~* liver disfunction~* HIV+~* Hepatitis B-C +~* Previous chemotherapy

- Gender: ALL
- Minimum Age: None
- Maximum Age: 69 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).